Early Clinical Experience With the CONSTELLATION® Vision System
By:  Pravin U. Dugel, MD
Safety is always a top priority, but increased efficiency is a critical benefit for the ASC

Leading Surgeons Introduce CONSTELLATION® Vision System
By:  Andrew E. Mathis, PhD, Medical Editor
The surgical system's advancements include 5000 cpm probes, duty cycle control, IOP control, xenon illumination, the PUREPOINT® Laser and V-LOCITY® Efficiency Components

Advanced Vitreous Cutter Offers Duty Cycle Control
By:  Peter K. Kaiser, M.D.
Unique design gives surgeons an important new parameter to manage

Recent Advances in Vitreoretinal Technology and Technique
By:  Stanislao Rizzo, MD; Marco Cinquini, MD
Safer, more efficient surgeries and new options for pharmacological management are now possible

How Advanced Vitrectomy Components Impact Surgical Efficiency
By:  George A. Williams, MD
V-LOCITY® Efficiency Components aim to optimize performance and minimize complications

The CONSTELLATION® Vision System: Assessing the Improvements in Illumination for Vitreoretinal Surgery
By:  Roger L. Novack, MD, PhD

Shedding More Light on Small-Gauge Vitrectomy
By:  David S. Dyer, MD
A review of new light sources and visualization techniques in minimally invasive vitrectomy

Surgical Experiences with the CONSTELLATION® Vision System
By:  Firas M. Rahhal, MD
Surgical observations of the new vitrectomy system

Recent Advances in 532 nm Green Laser Technology and Probe Enhancement: PUREPOINT® Laser Pre-Clinical and Clinical Assessment
By:  Timothy G. Murray, MD, MBA, FACS; Amy C. Schefler, MD; Yolanda Pina; Eleut Hernandez

New Innovations in Small-Gauge Instrumentation
By:  Marc J. Spirn, MD; Allen C. Ho, M.D.
Advances in 25-g and 23-g instrumentation are enabling surgeons to achieve outcomes equal to or better than those they can attain with 20-g instruments

Microincisional Vitrectomy: Techniques, Tips and the Future
By:  Mehran Taban, MD; Peter K. Kaiser, M.D.
A report on the impact of wound construction on successful transconjunctival vitrectomy

Intraocular Steroids in the Office
By:  Julia A. Haller, MD
New formulations offer preservative-free triamcinolone without relying on compounding pharmacies

The Use of Triamcinolone for Visualization During Vitreoretinal Surgery
By:  Richard H. Roe, MD, MHS; David S. Boyer, M.D.
Surgeons now have available the first FDA-approved chromovitrectomy agent

Upfront
By:  Jason S. Slakter, M.D.
Exploring New Technologies

Guest Editorial
By:  Kirk H. Packo, MD, FACS
The Evolution of Vitrectomy Technology: Do We Really Need Another Machine?

Subspecialty News
Small Incisions, Big Breakthroughs

Focus On ...
By:  Steve Charles, MD, FACS, FICS
Architecture of a New Vitrectomy System

Coding Q&A
By:  Riva Lee Asbell
The Top Retinal Surgical Coding Errors in 2008